Frailty and Longitudinal Physiologic Outcomes in Older Patients with Idiopathic Pulmonary Fibrosis

被引:0
|
作者
Sheth, J. S. [1 ]
Xia, M. [2 ]
Wang, Y. [2 ]
Murray, S. [2 ]
Meldrum, C. A. [1 ]
Belloli, E. A. [1 ]
Salisbury, M. L. [1 ]
White, E. S. [1 ]
Holtze, C. H. [1 ]
Wang, B. [1 ]
Flaherty, K. R. [1 ]
机构
[1] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A7133
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Longitudinal Health Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
    Molyneaux, P. L.
    Duggan, A.
    Fahy, W.
    Saini, G.
    Braybrooke, R.
    Marshall, R.
    Oballa, E.
    Kangombe, A.
    Jenkins, R. G.
    Maher, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [32] COMPOSITE PHYSIOLOGIC INDEX IN IDIOPATHIC PULMONARY FIBROSIS: EFFECTS OF NINTEDANIB
    Glaspole, I
    Wells, A.
    Behr, J.
    Stansen, W.
    Stowasser, S.
    Maher, T.
    RESPIROLOGY, 2018, 23 : 125 - 125
  • [33] Effects Of Emphysema On Physiologic And Prognostic Characteristics In Idiopathic Pulmonary Fibrosis
    Kim, T.
    Lee, S.
    Lee, S.
    Kim, N.
    Seo, J.
    Song, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
    Marialuisa Bocchino
    Paola Alicante
    Ludovica Capitelli
    Anna Agnese Stanziola
    Lorena Gallotti
    Ada Di Gregorio
    Gaetano Rea
    Alessandro Sanduzzi Zamparelli
    Luca Scalfi
    Scientific Reports, 11
  • [35] Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
    Bocchino, Marialuisa
    Alicante, Paola
    Capitelli, Ludovica
    Stanziola, Anna Agnese
    Gallotti, Lorena
    Di Gregorio, Ada
    Rea, Gaetano
    Sanduzzi Zamparelli, Alessandro
    Scalfi, Luca
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Workshop on Idiopathic Pulmonary Fibrosis in Older Adults
    Castriotta, Richard J.
    Eldadah, Basil A.
    Foster, W. Michael
    Halter, Jeffrey B.
    Hazzard, William R.
    Kiley, James P.
    King, Talmadge E., Jr.
    Horne, Frances McFarland
    Nayfield, Susan G.
    Reynolds, Herbert Y.
    Schmader, Kenneth E.
    Toews, Galen B.
    High, Kevin P.
    CHEST, 2010, 138 (03) : 693 - 703
  • [37] Impact of idiopathic pulmonary fibrosis on clinical outcomes of lung cancer patients
    Kim, Ho Cheol
    Lee, Seonjeong
    Song, Jin Woo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis
    Im, S. I.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [39] Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications
    Bryan T. Kelly
    Viengneesee Thao
    Timothy M. Dempsey
    Lindsey R. Sangaralingham
    Stephanie R. Payne
    Taylor T. Teague
    Teng Moua
    Nilay D. Shah
    Andrew H. Limper
    BMC Pulmonary Medicine, 21
  • [40] Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis
    Manon Belhassen
    Faustine Dalon
    Maëva Nolin
    Eric Van Ganse
    Respiratory Research, 22